Medtronic plc (MDTN.MX)
| Previous close | 1,455.00 |
| Open | 0.00 |
| Bid | 0.00 x 4700 |
| Ask | 0.00 x 200 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 76 |
| Market cap | 1.866T |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | 28.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 51.63 (3.55%) |
| Ex-dividend date | 28 June 2024 |
| 1y target est | N/A |
- PR Newswire
Medtronic announces departure of Karen Parkhill, Chief Financial Officer
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Karen Parkhill will resign as executive vice president and chief financial officer to accept the role of chief financial officer for HP Inc.
- PR Newswire
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of the MiniMed™ 780G system. New data shows how the system addresses hyperglycemia and nighttime burden, adding to the established body of evidence that demonstrates the system's ability to tackle unique and burdensome challenges of diabetes, such as managing highs and meal-time manage
- PR Newswire
Sempra Appoints Jennifer M. Kirk to Board of Directors
Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024. Kirk is currently the global controller and chief accounting officer of Medtronic plc (NYSE: MDT) and has deep executive experience in finance, accounting and capital market activities, including more than 20 years in the energy industry.
